DeepMind CEO Demis Hassabis: ‘AI could cut drug discovery from years to…’; how it is changing medicine worldwide |
Artificial intelligence (AI) is rapidly transforming industries, and the pharmaceutical sector is poised to be one of its most significant beneficiaries. In a recent Bloomberg Television interview, Demis Hassabis, CEO of DeepMind and Nobel laureate, revealed that AI could dramatically reduce drug discovery timelines, potentially cutting years of research down to mere months. DeepMind’s advanced…